Articles Published in 2009

Encorium Doubles Loss in Q2, Continues Effort to Sell European Subsidiary

Tuesday, August 25, 2009 07:08 AM

Encorium’s losses continued to grow in the second quarter, increasing $604,000  to $1.3 million or $(0.06) per diluted share, compared with a net loss of $665,000, or $(0.03) per diluted share for the same period last year.

More... »

SGS Partnership Helps Phase Forward Advance Business Strategy

Monday, August 24, 2009 06:50 AM

Phase Forward’s recent multi-million-dollar agreement with Swiss contract research organization (CRO) SGS Life Science Services not only provides the stability of a long-term contract to Phase Forward but also helps the eClinical provider advance its core strategy.

More... »

Averion Restructures as Revenues Dip

Friday, August 21, 2009 06:32 AM

Southborough, Mass.-based contract research organization (CRO) Averion is restructuring its senior management team in an effort to grow its services and improve its bottom line.

More... »

Covance Finalizes Merck Deal, Delays Construction of Preclinical Unit

Thursday, August 20, 2009 06:35 AM

Covance officially closed a deal with Merck earlier this week to provide genomics analysis services to the drug developer for the next five years. Under the terms of the $145-million agreement, the contract research organization (CRO) acquired Merck’s Seattle-based Gene Expression Laboratory. All Merck employees related to the Seattle facility became Covance employees as of August 17.

More... »

Datatrak Cuts Loss in Q2

Wednesday, August 19, 2009 06:22 AM

Struggling eClinical company Datatrak improved its financial outlook in the second quarter, cutting its net loss to $(39,000), or $0.00 per share on a basic and diluted basis, compared to a net loss of $(16,000,000), or $(1.17) per share, during the same period last year.

More... »

Guest Commentary: Serbia Celebrates International Day of Clinical Trials

Tuesday, August 18, 2009 07:29 AM

Serbia celebrated International Day of Clinical Trials, which was organized by the Section for Clinical Pharmacology (SCP) of the Serbian Medical Association (SMA). Founded in Belgrade in 1872, the Serbian Medical Association is the largest professional association of doctors in Serbia, who, through their sections, work on development of the medical profession and science in Serbia. The celebration was attended by physicians in all specialties, representatives of Serbian hospitals, contract research organizations (CROs) working in Serbia, sponsor representatives, as well as the management of the Serbian Medical Association.

More... »

Essential CRO Expands Global Reach through Ecron Acunova Partnership

Monday, August 17, 2009 06:47 AM

Up until a year ago, Gurnee, Ill.-based contract research organization (CRO) Essential CRO conducted most of its work in the United States, with a few projects in Canada and Mexico. Today, as a result of a strategic partnership with India-based Ecron Acunova, the company is growing its global footprint into India and Eastern Europe and plans to expand even more in the future.

More... »

Medidata Revenues Up 32% in Q2 Following IPO

Friday, August 14, 2009 10:58 AM

In Medidata Solutions’ first financial results since completing its initial public offering in June, the clinical trial software company’s second quarter net revenues jumped $8.3 million to $34 million, compared with $25.7 million for the same period last year.

More... »

Covance, MDS Pharma Earn MHRA Accreditation

Thursday, August 13, 2009 08:21 AM

Covance and MDS Pharma Services both recently earned standard and supplementary accreditation for the conduct of clinical pharmacology in Europe by the Medicines and Healthcare products Regulatory Agency (MHRA).

More... »

WuXi Posts Another Strong Quarter

Wednesday, August 12, 2009 06:39 AM

Chinese contract research organization (CRO) WuXi PharmaTech reported another quarter of profit growth with a 7% increase compared to the same period last year despite a drop in revenues.

More... »